Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Report map of MCI diagnostics and management
0
Zitationen
6
Autoren
2022
Jahr
Abstract
Deliverable 1.1 is a report mapping the mild cognitive impairment (MCI) diagnostics and management in the European countries participating in the project’s clinical study: Finland, Italy, Norway, and Spain. The purpose of this report is to identify the state-of-the-art tools and depict the current clinical practices used for the diagnosis and management of MCI in the four AI-Mind European countries participating in the project’s clinical study. Through a 22-question online survey (Annex I), we collected information on the diagnostics, treatment, and management of MCI, as well as on the clinicians’ acceptance and reliance on AI-based diagnostic tools. We analysed the collected data based on scientific literature and guidelines on how MCI is diagnosed, treated, and managed. Additionally, we mapped the healthcare professionals' expectations towards the clinical use of a potential digital AI-based tool for dementia risk-estimation, including issues like their view on reliability, trust, and anticipated patients' acceptance of such technology.
Ähnliche Arbeiten
The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research
1989 · 33.763 Zit.
Clinical diagnosis of Alzheimer's disease
1984 · 27.903 Zit.
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 · 24.617 Zit.
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
2013 · 20.643 Zit.
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 · 18.525 Zit.